301 companies
FRLN
Freeline Therapeutics Holdings plc
freeline is a biopharmaceutical company focused on the development and commercialisation of gene therapies for bleeding and other debilitating disorders based on a next-generation aav gene therapy platform developed by amit nathwani, professor of haematology at ucl and cso of freeline therapeutics http://www.freelinetx.com
United Kingdom
NASDAQ
FRTX
Fresh Tracks Therapeutics, Inc.
brickell biotech, inc.
Colorado
NASDAQ
FUSN
Fusion Pharmaceuticals Inc
fusion pharmaceuticals (www.fusionpharma.com) is a new pharmaceutical company located in hamilton, ontario, canada, that is focused on becoming the leader in the targeted alpha therapy field.
Ontario, Canada
NASDAQ
GMDAQ
Gamida Cell Ltd
gamida cell is a leader in cellular and immune therapeutics, committed to changing the treatment paradigm for patients with cancer and rare genetic diseases.
Israel
NASDAQ
CRXM
Gene Biotherapeutics, Inc.
Taxus Cardium Pharmaceuticals Group, Inc.
California
OTC
GNTA
Genenta Science SpA
cancer immunotherapy - our gene therapy science to treat cancer we develop a gene transfer strategy into autologous hematopoietic stem/progenitor cells (hspcs) to target interferon-α expression to tumor-infiltrating monocytes/macrophages.
Italy
NASDAQ
GTHR
Genethera Inc
GeneThera, Inc.
Colorado
NASDAQ
GENE
Genetic Technologies Ltd.
genetic technologies (asx: gtg, nasdaq global market: gene) is leading-edge genetic testing and reproductive services business which, together with an extensive range of international patents and allied research activities, aims at uncovering the impact of dna on health.
Australia
NASDAQ
GNFT
Genfit
genfit is a biopharmaceutical company at the forefront of developing therapeutic and diagnostic solutions in metabolic, inflammatory, autoimmune and fibrotic diseases, that affect the liver (such as nash - nonalcoholic steatohepatitis) or the bowel (such as the inflammatory bowel disease). genfit is committed to contribute to bringing new medicines to market for patients who lack suitable solutions, and strives to implement mutually beneficial approaches that combine novel drugs and biomarkers.
France
NASDAQ
GNCAQ
Genocea Biosciences, Inc.
Genocea's mission is to conquer cancer by developing personalized cancer immunotherapies in multiple tumor types.
Massachusetts
NASDAQ
Geoffrey F Cox
GILD
Gilead Sciences, Inc.
Gilead Sciences, Inc.
California
NASDAQ
DNA
Ginkgo Bioworks Holdings Inc - Ordinary Shares
the organism company ginkgo bioworks engineers new organisms to solve challenges across a range of industries from fuels to pharmaceutical production.
Massachusetts
NYSE
GPLB
Green Planet Bio Engineering Co. Ltd.
Florida
GRNA
GreenLight Biosciences Inc
greenlight biosciences is a privately-held biotechnology company focused on sustainable production of chemicals and fuels using its patented cell free bioprocessing technology platform.
Massachusetts
NASDAQ
Gregory D Phelps
GRTS
Gritstone Bio Inc
gritstone oncology is a cancer immunotherapy company developing next-generation personalized cancer therapeutics.
California
NASDAQ
Gyroscope Therapeutics Holdings plc
HALO
Halozyme Therapeutics Inc.
we are a clinical-stage biotechnology company focused on developing and commercializing novel cancer therapies that target the tumor microenvironment.
California
NASDAQ
HARP
Harpoon Therapeutics Inc
harpoon therapeutics is a pre-clinical stage biotechnology company co-founded by patrick bauerle, a pioneer in t-cell engagement, and luke evnin (mpm capital) in 2015 to develop and commercialize a novel class of t cell recruiting antibodies engage a patient’s own immune cells to fight cancer and other diseases.
California
NASDAQ